MedPath

Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population

Completed
Conditions
Conductive Hearing Loss
Hearing Loss
Atresia
Interventions
Device: Bone Achored Hearing surgery
Registration Number
NCT03723161
Lead Sponsor
Oticon Medical
Brief Summary

The purpose of this study is to in a proactive manner collect high quality data from a pediatric patients who have undergone a bone anchored hearing solution, using the Ponto BHX implant, in clinical practice. This to further increase the knowledge of using the system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients who have decided to undergo a Bone Anchored Hearing Surgery
  • Diagnosed with atresia
  • Signed informed consent
  • Patients between 2,5 - 18 years of age
  • Patients eligible for one stage surgery
Exclusion Criteria
  • Not fluent in Swedish or English; subject and/or legal guardian
  • Unwillingness to participate in follow up visits

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TreatmentBone Achored Hearing surgeryBone Anchored Hearing surgery using a BHX implant manufactured by Oticon Medical
Primary Outcome Measures
NameTimeMethod
Stability 12 months12 months post surgery

The development of implant stability during the first 12 months after implantation; as measured by difference in mean of (Implant Stability Quotient) ISQ low 12 months compared to surgery.

Secondary Outcome Measures
NameTimeMethod
Implant survival rate24 months post surgery

Implant survival rate in percent compared to litterature

Performance audibility PTA41 month post surgery

The difference between abutment-aided and softband-aided sound field Pure Tone Average of thresholds at frequencies 500, 1000, 2000 and 4000 Hz (PTA 4) in preoperative condition and at fitting.

Functional assessment12 months, 24 months

Functional assessment as measured by change in Pediatric Evaluation of Aural/Oral Performance of Children (PEACH)

Skin conditions Holger7-10 days,12 months, 24 months post surgery

Skin assessment as assessed with maximum Holgers score per patient. Maximum score 4. 0= no adverse skin reaction, 4=maximum adverse skin reaction.

Stability 24 months24 months post surgery

Difference in mean of ISQ low at 24 months compared to surgery

Performance speech intelligibility1 month post surgery

Difference between abutment-aided and softband-aided speech intelligibility in SNR in preoperative condition and at fitting.

Skin conditions IPS evaluation7-10 days,12 months, 24 months post surgery

Skin condition as assessed by (Inflammation, Pain, Skin height/numbness (IPS) score. I scale randing from 0-4, Pain scale ranging from 0-2, Height scale ranging from 0-2. Total score 8, 0=no adverse skin reaction, 8=maximum adverse skin reaction

Performance audibility1 month post surgery

Difference between abutment-aided and softband-aided sound field Pure Tone thresholds at frequencies 500, 1000, 2000, 4000, 6000 and 8000 Hz) in preoperative condition and at fitting

Sustainability of audibility performance1 month, 12 months, 24 months post surgey

Difference between abutment aided sound field Pure Tone thresholds at frequencies 500, 1000, 2000, 4000, 6000 and 8000 Hz over time

Sustainability of audibility PTA4 performance1 month, 12 months, 24 months post surgey

Difference between abutment aided sound field PTA 4 over time

Sustainability of speech intelligibility performance1 month, 12 months, 24 months post surgey

Difference between abutment aided speech intelligibility over time

Trial Locations

Locations (1)

Karolinska University Hospital

πŸ‡ΈπŸ‡ͺ

Stockholm, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath